Loading organizations...
Key people at Michigan Accelerator Fund.
Michigan Accelerator Fund I functions as an early-stage venture capital fund and investment partnership, primarily focused on providing crucial capital to high-potential companies within Michigan. Operating as an investment vehicle, it supplies financial resources to support the development and growth of emerging businesses, aiming to foster innovation and economic expansion across the state. The fund's strategic approach involves identifying promising ventures and delivering the necessary funding for their advancement.
Established as a 2012 vintage fund, Michigan Accelerator Fund I was co-managed by Charter Private Capital Management. The inception of the fund was driven by the recognized necessity to strengthen Michigan's entrepreneurial ecosystem, providing a dedicated source of funding for businesses that demonstrate significant growth prospects. This initiative emerged from an understanding that accessible capital is fundamental for nurturing the state's nascent and scaling enterprises.
The fund targets a diverse range of beneficiaries, from early-stage startups seeking initial investments to more mature, late-stage companies requiring further capital for expansion. Its overarching mission is to contribute to a robust and dynamic entrepreneurial economy in Michigan by actively investing in companies that are poised for substantial impact and long-term success, thereby cultivating a vibrant landscape for innovation.
Key people at Michigan Accelerator Fund.
Michigan Accelerator Fund has 5 tracked investments across 3 companies. The latest tracked deal is $77.0M Series D in Ablative Solutions in January 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 3, 2019 | Ablative Solutions | $77.0M Series D | — | Michael Fulton, Novus Biotechnology |
| Feb 4, 2014 | Ablative Solutions | $9.5M Series B | BioStar Ventures, Michigan Accelerator Fund | — |
| Oct 1, 2013 | Swift Biosciences | $7.0M Series B | Peter Kleinhenz | Mercury Fund, Renaissance Venture Capital Fund |
| Jun 19, 2012 | Ablative Solutions | $5.3M Series A | Steven L. Almany, Michigan Accelerator Fund | — |
| Jul 1, 2011 | Trapelo Health | $7.0M Series B | Beringea, Koleman Karleski | Hopen Life Science Ventures |